Janssen's full clinical studies to put on new schizophrenia drug.

Janssen Korea put a full clinical study for the new generation of schizophrenia drug, Paliperidone, especially focusing on 5 of phase III studies at 20 test centers and 1 of phase I study, the total 6 studies in Korea.

Janssen Korea said on Jan. 23 that the phase III studies would take place at 3 centers including SNU hospital, and 2 of the phase III studies of Paliperidone palmitate inject...